The Current Ratio as of November 2024 (TTM) for ContraFect Corporation (CFRX) is 0.53

According to ContraFect Corporation’s latest financial reports and current stock price. The company's current Current Ratio is 0.53. This represents a change of -35.51% compared to the average of 0.82 of the last 4 quarters.

ContraFect Corporation (CFRX) Historical Current Ratio (quarterly & annually)

How has CFRX Current Ratio performed in the past?

The mean historical Current Ratio of ContraFect Corporation over the last ten years is 5.78. The current 0.53 Current Ratio has changed 814.81% with respect to the historical average. Over the past ten years (40 quarters), CFRX's Current Ratio was at its highest in in the September 2017 quarter at 18.37. The Current Ratio was at its lowest in in the June 2014 quarter at 0.18.

ContraFect Corporation (CFRX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ContraFect Corporation Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ContraFect Corporation (CFRX) Average Current Ratio

How has CFRX Current Ratio performed in the past?

The current Current Ratio of ContraFect Corporation (CFRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ContraFect Corporation (CFRX) Current Ratio vs. Peers

How is CFRX’s Current Ratio compared to its peers?

ContraFect Corporation’s Current Ratio is less than Palisade Bio, Inc. (0), less than Allarity Therapeutics, Inc. (4.31), less than CNS Pharmaceuticals, Inc. (2.01), greater than Windtree Therapeutics, Inc. (0.31), greater than Quoin Pharmaceuticals, Ltd. (0.23), less than Revelation Biosciences, Inc. (3.35), less than Virax Biolabs Group Limited (1.10), less than Unicycive Therapeutics, Inc. (25.94), less than NeuroBo Pharmaceuticals, Inc. (3.37), less than Hillstream BioPharma, Inc. (2.94), less than First Wave BioPharma, Inc. (2.25), less than Dermata Therapeutics, Inc. (1.21), less than Panbela Therapeutics, Inc. (2.73), greater than null (0.05),

Build a custom stock screener for ContraFect Corporation (CFRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ContraFect Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ContraFect Corporation (CFRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ContraFect Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.